Body Composition

AOD-9604

AOD 9604 is a modified fragment of human growth hormone (hGH 176–191). It is being studied for its role in fat metabolism and lipolysis without the growth-promoting effects of full-length growth hormone.

280.00AED

per vial

Out of stock

Out of stock Blog 
  • Fast delivery Across the UAE, 2–4 days
  • Flexible payment Card, Tamara, bank transfer
  • Batch tested COA with every order

Specifications

Compound
AOD 9604 (Anti-Obesity Drug 9604)
CAS No.
221231-10-3
Molecular Weight
1815.1 g/mol
Purity
≥ 99% (HPLC)*
Strength
5 mg
Form
5 mg per vial
Molecular Target
Lipid metabolism (hGH C-terminal region)
Intended Use
Research Use Only

About this compound

AOD 9604 is a 16-amino-acid analogue of the C-terminal region of human growth hormone (residues 176–191), with tyrosine added at the N-terminus. It was developed as an anti-obesity candidate; clinical development was discontinued in 2007. Research focuses on lipolysis and fat metabolism without effects on blood glucose or IGF-1.

For research purposes only. This product is supplied exclusively for in-vitro laboratory research and analytical purposes. It is not intended for human or animal use, and must not be misused in any way that contravenes regulations or applicable laws.

  • Lipolysis: Fat breakdown in adipose tissue.
  • Lipogenesis: Inhibition of new fat formation.
  • Glucose Neutrality: Metabolic effects without changes in blood glucose.
  • IGF-1 Independence: Lipid effects without IGF-1 elevation.

Reviews